More stories

  • in

    Kevin Kwan, Author of ‘Crazy Rich Asians,’ Talks About His New Novel

    A reader of Kevin Kwan’s books could be forgiven for expecting him to make a grand entrance at lunch in Beverly Hills — in a Lamborghini, perhaps, or wearing a slick pair of shades.Instead, on an unseasonably brisk Tuesday in April, Kwan walked into the private dining at Crustacean with a tentative tilt to his head, as if clearing a low roof. He wore tortoiseshell glasses, a blue cardigan and hair cut for maximum pensive tucking behind ears. Picture David Foster Wallace minus the bandanna.Kwan immediately moved a vase of white roses from one table to another — “Do you mind? So we can see each other?” — then hugged Crustacean’s chef, “the great Helene An,” whose garlic noodles make a cameo in his new book, “Lies and Weddings,” coming out on May 21.To understand Kwan’s reputation for fabulousness, consider his oeuvre. His debut novel, “Crazy Rich Asians,” published in 2013, has sold more than 5 million copies worldwide and been translated into over 40 languages. A Broadway musical is in development. The movie version was the first since “The Joy Luck Club” to feature a majority Asian cast.Kwan’s next three novels covered similar territory: wealthy people behaving decadently and questionably, but usually with heart and always with panache. They were best sellers too. At one point, the “Crazy Rich Asians” trilogy occupied the top three spots on the paperback list, landing Kwan in an elite clique of authors including Colleen Hoover.The Times’s film critic described “Crazy Rich Asians” as “a busy, fizzy movie winnowed from Kevin Kwan’s sprawling, dishy novel.”Sanja Bucko/Warner Bros.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Legalized Weed is Landing More Seniors in the E.R.

    In Canada, cannabis poisonings rose sharply among people 65 and older after the country legalized the drug, a new study found.The NewsAs more places legalize marijuana, policymakers and health officials have worried about the health risks that the drug may pose to adolescents. But a new study suggests that an additional demographic is at risk: seniors.The study, published Monday in JAMA Internal Medicine, found that after Canada legalized marijuana, the number of emergency room visits for cannabis poisoning rose sharply among people ages 65 and older. Poisonings doubled after Canada legalized sale of the cannabis flower, and then tripled just 15 months later, when Canada legalized the sale of edibles.“It’s often a baked good, a chocolate or a gummy,” said Dr. Nathan Stall, a geriatrician at Mount Sinai Hospital and researcher at Women’s College Hospital in Toronto, and lead author on the study. Dr. Stall noted that researchers and emergency room doctors were finding that seniors used drugs intentionally but also sometimes by accident, when edibles were mistaken for regular food or snacks.Symptoms of cannabis poisoning can include dizziness, confusion, nausea, loss of coordination and balance, drowsiness and hallucinations.The findings were consistent with other research published in the United States, Dr. Stall said, and showed that more attention needed to be paid to drug use by seniors, and to the health effects.“It’s somewhat in the shadows, and there is some ageism and bias in thinking that older adults aren’t using drugs,” Dr. Stall said.Edible marijuana samples at a cannabis testing laboratory in Santa Ana, Calif.Chris Carlson/Associated PressThe StudyThe study looked at 2,322 emergency room visits for cannabis poisoning among people 65 and older in Ontario. The visits spanned 2015 through 2022, allowing researchers to see what happened before and after October 2018, when Canada legalized the sale of dried cannabis, and January 2020, when the sale of edibles was legalized.In 2015, there were 55 emergency room visits caused by cannabis poisoning. That figure rose steadily to 462 by 2021, and then fell off slightly to 404 in 2022.Dr. Stall said he was motivated to undertake the study after being called into the emergency room to consult on an octogenarian who was experiencing severe confusion. The patient was barely conscious and showed strokelike symptoms. Multiple tests revealed no clear cause, until Dr. Stall ordered a toxicology test and found cannabis in the patient’s urine.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Why Adult ADHD Is Hard to Diagnose

    It’s one of the most common psychiatric disorders in adults. Yet there are no U.S. guidelines for diagnosing and treating patients beyond childhood.Just before Katie Marsh dropped out of college, she began to worry that she might have attention deficit hyperactivity disorder.“Boredom was like a burning sensation inside of me,” said Ms. Marsh, who is now 30 and lives in Portland, Ore. “I barely went to class. And when I did, I felt like I had a lot of pent-up energy. Like I had to just move around all the time.”So she asked for an A.D.H.D. evaluation — but the results, she was surprised to learn, were inconclusive. She never did return to school. And only after seeking help again four years later was she diagnosed by an A.D.H.D. specialist.“It was pretty frustrating,” she said.A.D.H.D. is one of the most common psychiatric disorders in adults. Yet many health care providers have uneven training on how to evaluate it, and there are no U.S. clinical practice guidelines for diagnosing and treating patients beyond childhood.Without clear rules, some providers, while well-intentioned, are just “making it up as they go along,” said Dr. David W. Goodman, an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine.This lack of clarity leaves providers and adult patients in a bind.“We desperately need something to help guide the field,” said Dr. Wendi Waits, a psychiatrist with Talkiatry, an online mental health company. “When everyone’s practicing somewhat differently, it makes it hard to know how best to approach it.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    A Former Leader of the Hells Angels Motorcycle Gang Joins Trump in Court

    An entourage of more than a dozen supporters who joined President Donald J. Trump in a Manhattan courthouse on Monday included a former president of an outlaw motorcycle gang in New York City who spent years in prison on drug charges.The man, Chuck Zito, helped found in the early 1980s the New York Nomads chapter of the Hells Angels, the infamous club that started in California. The Justice Department described the organization as a criminal enterprise and linked the New York chapter to the Gambino crime family. Mr. Zito later left the biker group to try become a movie star in Hollywood.Mr. Trump has long shown an affection for macho bikers, and addressed a rally of them in Washington in 2016 before the election. (“Do we love the bikers? Yes. We love the bikers,” he told the crowd.) A group called Bikers for Trump took part in several so-called Stop the Steal rallies after Mr. Trump lost the 2020 election.Mr. Zito was joined in the courtroom on Monday by several Trump allies who have been charged with crimes.They included Boris Epshteyn, a legal adviser indicted in an Arizona case related to attempts to keep Mr. Trump in power after the 2020 election, and Bernard Kerik, the former commissioner of the New York Police Department, who was imprisoned for tax-related charges and later pardoned by Mr. Trump. The entourage was so large that Mr. Epshteyn helped coordinate seating.Mr. Zito has experience with the criminal justice system, having served a prison term from 1985 to 1991 on drug conspiracy charges. In recent decades, he has created a new career as a stuntman and occasional actor, starring most prominently as Chucky “The Enforcer” Pancamo in the HBO prison drama “Oz.”Mr. Zito is also something of a professional tough-guy-about-town with many acquaintances in New York and Hollywood. He once served as a boxing trainer for the actor Mickey Rourke, and when the mob boss John Gotti died of cancer in 2002, Mr. Zito was one of the few non-Mafia members to attend the wake at a funeral home in Queens. More

  • in

    Emma Stone, Jesse Plemons and Willem Dafoe on Yorgos Lanthimos’s New Film

    In the new Yorgos Lanthimos film “Kinds of Kindness,” a character played by Emma Stone recounts a dream in which she was the denizen of a bizarre world. “There, dogs were in charge,” she murmurs. “People were animals, animals were people.” But being brought to heel by their canine masters wasn’t as bad as it sounds, she says: “I must admit, they treated us pretty well.”Compared with how the human beings treat each other in “Kinds of Kindness,” a dark new comedy that just premiered at the Cannes Film Festival and is in theaters June 21, the dogs would surely be an improvement.Comprised of three separate stories with the cast members recurring in different roles, “Kinds of Kindness” begins with the tale of Robert (Jesse Plemons), a corporate underling whose every interaction in life — including what to eat, how to speak or even who to marry — is controlled by a boss (Willem Dafoe) whose decisions send poor Robert into a tailspin. The second story follows Daniel (Plemons again), who becomes convinced that his wife (Stone) is not who she claims to be and coaxes her into insane tasks to prove herself.And in the third sequence, cult members played by Stone and Plemons search for a woman able to wake the dead, though the whims of their guru (Dafoe) dictate that this mysterious woman also be a certain height and weight and have an identical twin. (Even when it comes to awesome supernatural powers, there are dealbreakers.)Dafaoe and Stone worked on Lanthimos’s “Poor Things” together, for which she won the best actress Oscar. “I still don’t know what that was,” Stone said. “That was cuckoo bananas.” Sam Hellmann for The New York TimesOn Saturday afternoon in a hotel here in Cannes, I met with Stone, Plemons and Dafoe to try to make sense of this triptych. According to the actors, Lanthimos isn’t keen to give too much away. “Yorgos says he likes it when people have different takes on the movie,” Dafoe said. “I think that’s the strength of it.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Report Finds ‘Catalog of Failures’ in U.K. Contaminated Blood Scandal

    A six-year inquiry found that the deaths of about 3,000 people and the infection of tens of thousands of others could have mostly been avoided.A “catalog of failures” by government and medical officials in Britain, most of them avoidable errors, led to blood contaminations that killed about 3,000 people and infected more than 30,000 others over two decades, according to a long-awaited report published on Monday.The report is the product of a six-year inquiry that the British government ordered in 2017 after decades of pressure from victims and their families, and it could pave the way for sizable compensation payments.The independent report puts a harsh spotlight on Britain’s state-run National Health Service, identifying “systemic, collective and individual failures” by British authorities as they dealt with the infections of tens of thousands of people by tainted blood transfusions or contaminated blood products between the 1970s and the 1990s.The authorities at the time refused to acknowledge those failings — including the lack of proper screening and testing of blood — by “hiding the truth,” the report said.“This disaster was no accident,” Brian Langstaff, a former High Court judge who led the inquiry, said at a news conference on Monday. “People put their trust in doctors and the government to keep them safe, and that trust was betrayed.”He added, “The N.H.S. and successive governments compounded the agony by refusing to accept that wrong had been done.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Schumer Announces Senate Will Vote Again on Border Bill

    The bipartisan border enforcement compromise, blocked by Republicans in February, is all but certain to be thwarted again. Democrats aim to tag the G.O.P. as the culprit in its failure.Senator Chuck Schumer, Democrat of New York and the majority leader, plans to push forward this week with a second vote on a bipartisan border enforcement bill that Senate Republicans killed earlier this year at the urging of former President Donald J. Trump.The measure is almost certain to be blocked again, but Democrats hope to use the failed vote to sharpen an election-year contrast with the G.O.P. on a critical issue that polls show is a major potential liability for President Biden and their candidates.Democrats will aim to neutralize the issue by showing voters that they and Mr. Biden have tried to get migration at the U.S. border with Mexico under control, but have been thwarted repeatedly by Republicans following the lead of Mr. Trump.“The former president made clear he would rather preserve the issue for his campaign than solve the issue in a bipartisan fashion,” Mr. Schumer wrote in a letter to colleagues that heralded the bill’s provisions and outlined his plans. “On cue, many of our Republican colleagues abruptly reversed course on their prior support, announcing their newfound opposition to the bipartisan proposal.”After months of negotiation, Republicans and Democrats reached an improbable immigration compromise in February — one that G.O.P. lawmakers had insisted was a prerequisite for providing additional aid to Ukraine — that appeared to have a chance at passage. But Mr. Trump called it too weak and instructed his allies in Congress to vote it down. The measure failed when it fell short of the 60 votes needed to advance in the Senate, with all but four Republicans voting to block it. (In the 50-to-49 vote, three Democrats and one independent also voted “no,” denying the measure even a simple majority.)Mr. Biden, whose team helped hammer out the deal, urged support for it on Monday in a statement from Karine Jean-Pierre, the White House press secretary, that said, “We strongly support this legislation and call on every senator to put partisan politics aside and vote to secure the border.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

  • in

    Russia’s War Machine Revs Up as the West’s Plan to Cap Oil Revenues Sputters

    Russia has largely evaded attempts by the U.S. and Europe to keep it from profiting from its energy exports.The United States and its allies in the Group of 7 nations set two goals in 2022 when they enacted a novel plan to cap the price of Russian oil: restrict Moscow’s ability to profit from its energy exports while allowing its oil to continue flowing on international markets to prevent a global price shock.A year and a half later, only the latter goal appears to have worked. Energy prices have been relatively stable across the world, including in the United States, which helped devise the plan. But Russia’s war effort in Ukraine is intensifying, making it increasingly clear that efforts by Western allies to squeeze Moscow’s oil revenues are faltering.A variety of factors have allowed Russia to continue profiting from strong oil revenue, including lenient enforcement of the price cap. Russia’s development of an extensive “shadow” fleet of tankers has allowed it to largely circumvent that policy. That has allowed the Russian economy to be more resilient than expected, raising questions about the effectiveness of the coordinated sanctions campaign employed by the G7.The Biden administration maintains that the strategy has been effective and that the price cap has imposed costs on Russia and forced it to redirect money that it would have used in Ukraine to finance an alternative oil ecosystem.Treasury Secretary Janet L. Yellen said in an interview on Sunday that the price of Russian oil was not the only measure of their profits, noting that Russia has had to invest significant resources in response to the cap.“We’ve made it very expensive for Russia to ship this oil to China and India in terms of acquiring a shadow fleet and providing insurance,” Ms. Yellen said on her flight to Europe, where she is holding meetings in Germany and attending a gathering of finance ministers in Italy. “We still think it’s working.”We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More